Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response
about
Tumor-associated stromal cells as key contributors to the tumor microenvironmentSpatiotemporal oxygen sensing using dual emissive boron dye-polylactide nanofibers.Direct visualization of the phenotype of hypoxic tumor cells at single cell resolution in vivo using a new hypoxia probe.Investigating microenvironmental regulation of human chordoma cell behaviourOptimizing radiotherapy protocols using computer automata to model tumour cell death as a function of oxygen diffusion processesHypoxia-induced p53 modulates both apoptosis and radiosensitivity via AKTObstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma.Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancerKill-painting of hypoxic tumours in charged particle therapy.Mechanisms and consequences of ATMIN repression in hypoxic conditions: roles for p53 and HIF-1.Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition.Potential role of the glycolytic oscillator in acute hypoxia in tumors.Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium.The role of hypoxia in pancreatic cancer: a potential therapeutic target?Hypoxia inducible factors in hepatocellular carcinomaCharged-particle therapy in cancer: clinical uses and future perspectives.Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs.Hypoxia-driven splicing into noncoding isoforms regulates the DNA damage response.Hypoxia: A Double-Edged Sword in Cancer Therapy.Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells.BJR radiobiology special feature.Inhibition of HIF1α and PDK Induces Cell Death of Glioblastoma Multiforme.Fluorous photosensitizers enhance photodynamic therapy with perfluorocarbon nanoemulsions.A Microdevice Platform Recapitulating Hypoxic Tumor Microenvironments.Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation.Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy: retrospective analysis and preclinical modeling.Influence of salinomycin treatment on division and movement of individual cancer cells cultured in normoxia or hypoxia evaluated with time-lapse digital holographic microscopy.Human Mesenchymal Stem Cell Failure to Adapt to Glucose Shortage and Rapidly Use Intracellular Energy Reserves Through Glycolysis Explains Poor Cell Survival After Implantation.The unidirectional hypoxia-activated prodrug OCT1002 inhibits growth and vascular development in castrate-resistant prostate tumors.Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome.S100A7: from mechanism to cancer therapy.Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma.Glutamine Synthetase: Localization Dictates Outcome.The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.Tumor stressors induce two mechanisms of intracellular p-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones.Targeting active cancer cells with smart bullets.PhysiCell: An open source physics-based cell simulator for 3-D multicellular systems.Targeting autophagy in chemotherapy-resistant of hepatocellular carcinoma.The cellular stress proteins CHCHD10 and MNRR1 (CHCHD2): Partners in mitochondrial and nuclear function and dysfunction.Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.
P2860
Q26741825-8872939B-AA83-4FAF-A7BA-4CEC0F9BAAC4Q27335036-88E45B91-DC40-4028-B2AA-02FCA74B3396Q30826469-D82214FE-F9BA-48D3-9128-BA9A337CBAC9Q33275485-37B95271-0437-469D-8BD0-FF80650C25AAQ33720072-4F62F5BF-C1FB-4CFE-BCAD-F7F9BB3A81F0Q35836156-C558ED62-15D3-4DDB-9442-53D0505B3DA2Q36161453-9460B188-DE3F-490B-92A9-B1D000D79C8EQ36214623-D57C4FD0-4D3C-4225-9E03-2D14F03760CCQ36310285-F3B61B45-03CD-4107-BFDD-A2BF1A386854Q36580272-7E312E70-CFBB-478D-B0E4-347158262C93Q36707740-3BCD811D-BF6A-408C-B9EF-EC3EDE0BD1DBQ36803797-0850460B-2D2B-4B59-8DF6-0BE43D46BBCFQ38263008-2B3F464B-4C62-407A-93ED-7713041126C1Q38631404-64FF1437-F507-4C30-A8C4-0B7463C67468Q38685135-F43E1CB5-3C9C-41B8-8B59-C0DF2DD4CBC0Q38746213-D20F80B5-AFE3-4930-B401-AE6D09AF6A62Q38783493-DCE49F94-AA3C-4B43-84C8-558E5330DFD8Q38799220-A64E160A-D617-4AEA-A072-4E3B899A0846Q39002822-F56A8630-E5D6-4559-90D4-9FC289180C06Q39415253-48D594FC-6E1C-4355-8546-9B849CEF3DB0Q42703353-B5D8ABFB-DFE5-4246-935C-ECCB88AF6F8EQ43725271-0089555D-EEC9-483E-AC5E-1118F17430ACQ46064664-5E14F675-88FD-4008-886C-25F803ADA7D1Q46768239-6C495372-5A9E-4ADD-A2C9-4E5013E463FDQ47139818-6C22731B-3CE2-468D-AA66-736893C4FD12Q47143527-49CFBD9E-0C5D-48B3-883E-F7DF257F8A74Q47158789-3D916D24-060B-486C-93A8-5E75CF8CD8B7Q47228732-6BD11C4B-240E-435A-9E11-8B2CD199D9A6Q47763534-E1C7116D-E92F-453F-B227-B73E0462D712Q47769995-1B86C3ED-A11C-4EEF-9A09-7D0E527AD903Q47927472-B1AC177D-5EAE-4577-B33D-EE15959D98C5Q47948966-07CC6CE8-8750-4823-A5AC-D921113F963CQ49798196-D465D1A3-8B99-40B3-BD34-A80C543E3CA3Q50062142-36EAAFF8-3A19-4585-BF26-BD5D006BF95EQ50158298-B53D2DEB-7A49-421E-8781-AE408E7D1D67Q50938724-F2AE9A8D-9681-4B60-95D6-C68489B3C380Q52688323-D7EF9BBB-8D24-43A8-8FA9-52581C2B0340Q53696566-DFF95743-5E29-4B09-8AAE-8C43EA2BE2E9Q54982145-16E490DB-C94D-4616-9791-700ED93FDD11Q55398136-3E544F60-D50C-4A5E-A39A-CDA847D2C557
P2860
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response
@ast
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response
@en
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response
@nl
type
label
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response
@ast
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response
@en
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response
@nl
prefLabel
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response
@ast
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response
@en
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response
@nl
P2860
P3181
P356
P1476
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response
@en
P2093
S R McKeown
P2860
P304
P3181
P356
10.1259/BJR.20130676
P407
P577
2014-03-01T00:00:00Z